Post-operative endometriosis recurrence: A plea for prevention based on pathogenetic, epidemiological and clinical evidence

Paolo Vercellini, Edgardo Somigliana, Paola Vigan, Sara De Matteis, Giussy Barbara, Luigi Fedele

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Prevention of the recurrence of post-operative endometriosis is crucial for future fertility. The incidence of disease relapse can be influenced by major demographic changes and by the use of long-term adjuvant medical treatment. Decrease in age at menarche, number of pregnancies and duration of breastfeeding and increase in age at first birth all lead to an increase in the overall number of ovulations and menstruations a woman has within a reproductive lifespan. These changes impact during the decade at highest risk for endometriosis, i.e. between 25 and 35 years of age, and may substantially expand the hiatus between first-line surgical treatment and conception attempt. Several lines of evidence suggest that ovulation inhibition reduces the risk of endometriosis recurrence. After pooling the results of a cohort and a randomized controlled trial on long-term post-operative oral contraceptive use, a recurrent endometrioma developed in 26/250 regular users (10%; 95% CI 7-15%) compared with 46/115 never users (40%; 95% CI 31-50%), with a common OR of 0.16 (95% CI 0.04-0.65). After first-line surgery for endometriosis, women should be invited to seek conception as soon as possible. Alternatively, oral contraceptive use until pregnancy is desired should be considered.

Original languageEnglish
Pages (from-to)259-265
Number of pages7
JournalReproductive BioMedicine Online
Volume21
Issue number2
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Endometriosis
Recurrence
Oral Contraceptives
Ovulation Inhibition
Pregnancy
Menarche
Birth Order
Menstruation
Ovulation
Breast Feeding
Fertility
Randomized Controlled Trials
Demography
Incidence
Therapeutics

Keywords

  • endometriosis
  • medical treatment
  • oral contraceptives
  • prevention
  • recurrence
  • surgery

ASJC Scopus subject areas

  • Reproductive Medicine
  • Developmental Biology

Cite this

Post-operative endometriosis recurrence : A plea for prevention based on pathogenetic, epidemiological and clinical evidence. / Vercellini, Paolo; Somigliana, Edgardo; Vigan, Paola; De Matteis, Sara; Barbara, Giussy; Fedele, Luigi.

In: Reproductive BioMedicine Online, Vol. 21, No. 2, 08.2010, p. 259-265.

Research output: Contribution to journalArticle

@article{a2b3b16b22784cd582687f6091a1175e,
title = "Post-operative endometriosis recurrence: A plea for prevention based on pathogenetic, epidemiological and clinical evidence",
abstract = "Prevention of the recurrence of post-operative endometriosis is crucial for future fertility. The incidence of disease relapse can be influenced by major demographic changes and by the use of long-term adjuvant medical treatment. Decrease in age at menarche, number of pregnancies and duration of breastfeeding and increase in age at first birth all lead to an increase in the overall number of ovulations and menstruations a woman has within a reproductive lifespan. These changes impact during the decade at highest risk for endometriosis, i.e. between 25 and 35 years of age, and may substantially expand the hiatus between first-line surgical treatment and conception attempt. Several lines of evidence suggest that ovulation inhibition reduces the risk of endometriosis recurrence. After pooling the results of a cohort and a randomized controlled trial on long-term post-operative oral contraceptive use, a recurrent endometrioma developed in 26/250 regular users (10{\%}; 95{\%} CI 7-15{\%}) compared with 46/115 never users (40{\%}; 95{\%} CI 31-50{\%}), with a common OR of 0.16 (95{\%} CI 0.04-0.65). After first-line surgery for endometriosis, women should be invited to seek conception as soon as possible. Alternatively, oral contraceptive use until pregnancy is desired should be considered.",
keywords = "endometriosis, medical treatment, oral contraceptives, prevention, recurrence, surgery",
author = "Paolo Vercellini and Edgardo Somigliana and Paola Vigan and {De Matteis}, Sara and Giussy Barbara and Luigi Fedele",
year = "2010",
month = "8",
doi = "10.1016/j.rbmo.2010.04.018",
language = "English",
volume = "21",
pages = "259--265",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier Ltd",
number = "2",

}

TY - JOUR

T1 - Post-operative endometriosis recurrence

T2 - A plea for prevention based on pathogenetic, epidemiological and clinical evidence

AU - Vercellini, Paolo

AU - Somigliana, Edgardo

AU - Vigan, Paola

AU - De Matteis, Sara

AU - Barbara, Giussy

AU - Fedele, Luigi

PY - 2010/8

Y1 - 2010/8

N2 - Prevention of the recurrence of post-operative endometriosis is crucial for future fertility. The incidence of disease relapse can be influenced by major demographic changes and by the use of long-term adjuvant medical treatment. Decrease in age at menarche, number of pregnancies and duration of breastfeeding and increase in age at first birth all lead to an increase in the overall number of ovulations and menstruations a woman has within a reproductive lifespan. These changes impact during the decade at highest risk for endometriosis, i.e. between 25 and 35 years of age, and may substantially expand the hiatus between first-line surgical treatment and conception attempt. Several lines of evidence suggest that ovulation inhibition reduces the risk of endometriosis recurrence. After pooling the results of a cohort and a randomized controlled trial on long-term post-operative oral contraceptive use, a recurrent endometrioma developed in 26/250 regular users (10%; 95% CI 7-15%) compared with 46/115 never users (40%; 95% CI 31-50%), with a common OR of 0.16 (95% CI 0.04-0.65). After first-line surgery for endometriosis, women should be invited to seek conception as soon as possible. Alternatively, oral contraceptive use until pregnancy is desired should be considered.

AB - Prevention of the recurrence of post-operative endometriosis is crucial for future fertility. The incidence of disease relapse can be influenced by major demographic changes and by the use of long-term adjuvant medical treatment. Decrease in age at menarche, number of pregnancies and duration of breastfeeding and increase in age at first birth all lead to an increase in the overall number of ovulations and menstruations a woman has within a reproductive lifespan. These changes impact during the decade at highest risk for endometriosis, i.e. between 25 and 35 years of age, and may substantially expand the hiatus between first-line surgical treatment and conception attempt. Several lines of evidence suggest that ovulation inhibition reduces the risk of endometriosis recurrence. After pooling the results of a cohort and a randomized controlled trial on long-term post-operative oral contraceptive use, a recurrent endometrioma developed in 26/250 regular users (10%; 95% CI 7-15%) compared with 46/115 never users (40%; 95% CI 31-50%), with a common OR of 0.16 (95% CI 0.04-0.65). After first-line surgery for endometriosis, women should be invited to seek conception as soon as possible. Alternatively, oral contraceptive use until pregnancy is desired should be considered.

KW - endometriosis

KW - medical treatment

KW - oral contraceptives

KW - prevention

KW - recurrence

KW - surgery

UR - http://www.scopus.com/inward/record.url?scp=78649584804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649584804&partnerID=8YFLogxK

U2 - 10.1016/j.rbmo.2010.04.018

DO - 10.1016/j.rbmo.2010.04.018

M3 - Article

C2 - 20541975

AN - SCOPUS:78649584804

VL - 21

SP - 259

EP - 265

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 2

ER -